PBE icon

Invesco Biotechnology & Genome ETF

92 hedge funds and large institutions have $81.6M invested in Invesco Biotechnology & Genome ETF in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 36 reducing their positions, and 5 closing their positions.

Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
14
Reduced
36
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
PNC Financial Services Group
76
PNC Financial Services Group
Pennsylvania
$21.1K 329 -68 -17%
AssetMark Inc
77
AssetMark Inc
California
$20.8K 325
LAM
78
LOM Asset Management
$19K 300 +300 New
PC
79
Promus Capital
Illinois
$18.1K 282
S
80
SignatureFD
Georgia
$13.7K 213
ME
81
McIlrath & Eck
Washington
$13.1K 205
Comerica Bank
82
Comerica Bank
Texas
$13K 203
TFGT
83
TS Financial Group (TSFG)
Illinois
$13K 200
FA
84
Financial Avengers
California
$12.8K 200
Citigroup
85
Citigroup
New York
$12.8K 200
CPG
86
Cornerstone Planning Group
New Jersey
$10.9K 164
FHA
87
First Horizon Advisors
Tennessee
$10K 156
HIA
88
Harbor Investment Advisory
Maryland
$9.62K 150
MCM
89
MAI Capital Management
Ohio
$8.01K 125
PA
90
Parallel Advisors
California
$5.57K 87 +31 +55%
AIP
91
Ameritas Investment Partners
Nebraska
$4.49K 70
BBPWM
92
Blue Bell Private Wealth Management
Pennsylvania
$1.35K 21
RF
93
Robbins Farley
New Hampshire
$193 3
NC
94
North Capital
Utah
$128 2
HNB
95
Huntington National Bank
Ohio
JIC
96
Joel Isaacson & Co
New York
-6,730 Closed
Two Sigma Investments
97
Two Sigma Investments
New York
-3,900 Closed
CCM
98
Coldstream Capital Management
Washington
-228 Closed
T
99
Tidemark
California
-91 Closed
PPA
100
Painted Porch Advisors
California
-49 Closed